Photo taken from Anwaar Saeed/X
May 18, 2024, 00:02
Anwaar Saeed: Excited to announce the launch of PARAMUNE trial!
Anwaar Saeed, Associate Professor and Chief of Gastrointestinal Medical Oncology at University of Pittsburgh, shared a post by NCI CTEP Clinical Research, on X:
“Excited to announce the launch of PARAMUNE trial! Grateful to my supporters SWOG, NCI CTEP Clinical Research. Together, we’re pioneering frontiers in immunotherapy, offering hope to those in need. Let’s make a difference!“
Quoting NCI CTEP Clinical Research‘s post:
“Newly Activated NCTN Esophageal Cancer Gastroesophageal Cancer Trial: (S2303) Adding Nivolumab to Usual Treatment for People With Advanced Stomach or Esophageal Cancer, The PARAMMUNE Trial, led by Dr. Saeed, UPMC Hillman Cancer Center, SWOG.”
Read further.
Source: Anwaar Saeed/X and NCI CTEP Clinical Research/X